Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis

SIMPLE SUMMARY: Multiple myeloma patients have benefited from bortezomib therapy, though it has often been discontinued owing to diarrhea. The objective of this study was to verify serum bortezomib concentration in the emergence of diarrhea. Twenty-four patients with bortezomib therapy were recruite...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Yuki, Ueno, Shikiko, Oda, Kazutaka, Gunda, Nao, Shimomura, Yumi, Nishimura, Yuka, Yamaguchi, Ayami, Kuwano, Akari, Ito, Yuki, Baba, Yusuke, Nishigaki, Aina, Michiwaki, Natsumi, Uchino, Shota, Kurogi, Kayo, Kawano, Yawara, Matsuoka, Masao, Saito, Hideyuki, Okuno, Yutaka, Jono, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616141/
https://www.ncbi.nlm.nih.gov/pubmed/34830830
http://dx.doi.org/10.3390/cancers13225674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616141/
https://www.ncbi.nlm.nih.gov/pubmed/34830830
http://dx.doi.org/10.3390/cancers13225674

Ejemplares similares